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In Pirkei Avot, a prominent collection of Jewish ethics and morals, Shimon ben Zoma 
is quoted: “Who is wise?  He who learns from all people.”  This phrase has been 
somewhat of a guiding principle for me throughout my graduate studies, and throughout 
my time at Caltech I have been surrounded by an incredible group of people.  These are 
the many students, professors and staff who have contributed toward my development as 
a scientist and have provided me with plenty of lessons in life and in Chemistry.  I have 
resigned myself to the knowledge that this section will invariably be inadequate to 
address every manner in which I have been changed for the better by my interactions at 
this singular institution. 
Foremost, I must thank my supervisor, Prof. Brian Stoltz.  From day one, Brian has 
challenged me, encouraged me to challenge myself, and supported my efforts every step 
of the way.  Brian is an endless source of knowledge and ideas; every time I’ve spoken to 
him about my project, whether in subgroup or in one-on-one meetings, I have left 
reenergized and motivated.  Brian is an exceptionally caring person, and I truly 
appreciate the extent to which he will go to bat for his students.  In addition, I’ve been 
privileged to spend time with his family, Erna, Harry, and Teddy at our group events.  
I also thank my thesis committee members, Profs. Bob Grubbs, Jonas Peters, and 
Sarah Reisman.  During our meetings and throughout my education at Caltech, they have 
provided me with indispensable advice on my research and have served as formidable 
role models for their creativity, leadership, and collegiality.  It has been a privilege to 
watch Sarah’s group develop from the beginning of her independent academic career.  
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The imprint that she has already made in the field of organic synthesis in her first five 
years is impressive, evidenced by the growing number of publications in the Schlinger 
hallway and the number of Synfacts highlights outside her office door!  I’ve also enjoyed 
interacting with Prof. Theo Agapie, whose exciting research ideas almost turned me into 
an inorganic chemist in my first year.  I’m also glad that he hasn’t held me to the 30 
reactions I promised him at various recruitment events; I swear I would have done them 
if he asked, but I am confident there’s a statute of limitations on things like this. 
Many thanks also go out to my former academic supervisors, including Dr. Chaim 
Bell, Prof. Cathleen Crudden, Prof. Mark Lautens, and Prof. Ilan Marek, as well as the 
graduate students and postdocs who have directly trained me: Kevin McEleney, Chris 
Lata, Dave Hulcoop, and Samah Simaan.  I am forever indebted to all of them for the 
indispensable guidance and training, and for stimulating my excitement for scientific 
research.  Several of my teachers in elementary school and high school are responsible 
for instilling my love of learning, in particular, Mme. Carmen Jessop, Mrs. Brenda 
Silverberg, and Mr. Gary Levine. 
As for my co-workers, so many deserve my thanks.  For starters, far be it from me to 
take advice from a bathroom wall, but one in Crellin needs special recognition.  It says, 
“when in doubt, ask Mike Krout”.  I had many doubts to ask about, and he was always 
(and continues to be) willing to share his experience and wisdom.  One of these pearls: 
success as an undergrad is all about what you know; in graduate school, it’s about what 
you can do.  Well, during my time in Brian’s lab, I’ve been surrounded by incredible 
thinkers and do-ers from the US and around the world.  Special thanks go out to my 
friend Jonny Gordon, The Jonald, Jonnyboy, Jonny-B, the better half of team Joosball, 
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etc.  From the late-nights in second-year writing our candidacy reports, to the epic 
billion-or-so reaction screen that we tag-teamed and that didn’t produce any tangible 
results, the good times and the hard times, but particularly the hard times, Jonny has been 
through the rigors of grad school along my side, and has always had a way of putting 
things in perspective for me that I’ve come to truly appreciate.  
 Chris Henry and Kristy Tran were among the most selfless individuals to have 
graced our lab in my time here.  If you asked Florian Vogt the question, “Have you tried 
the _____ reaction?” you could be certain the answer would be an emphatic “Yes.”  
Thomas Jensen and Kathrin Höferl-Prantz were models for time-management and 
efficiency, and are wonderful scientists and people all-around.  Beyond the lab, I have 
fond memories of skiing weekends in Mammoth with Jan Streuff, Helene Kolding and 
Corinne Baumgartner.  It is beyond me how Josh Day managed to raise two and a half 
children and complete an epic total-synthesis at the same time.  After spending enough 
time in lab with Michele Gatti, it became clear why he was the one who set the record for 
shortest time to publication in the Stoltz group: he kind of knows everything, and knows 
how to do everything.  Though I may never forgive him for encouraging me to spend 
days trying to find separation conditions on the chiral SFC for what turned out to be an 
achiral compound!  I would be remiss if I did not mention the rest of team Germany, 
including Christians Eidamshaus and Grünanger, Alex Marziale, and Hendrik “Jimi” 
Klare.  It is thanks to them that I know useful German phrases, including “Ich heisse Alex 
und komme aus Kanada” and “Du bist sehr hübsch, komm mit mir in mein iglu”.  Thanks 
to my compatriot Guillaume Lapointe who has studied chemistry in more countries than 
my thesis beard has patches, and has shared his wealth of knowledge to everybody’s gain.  
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It’s always a pleasure working around Boger Liu: his smile is contagious.  I also had the 
fortune of working with Doug Behenna on his second tour of duty in the group; if 
something was broken, he’d fix it, if you had a problem, he’d solve it.  John Enquist, for 
teaching me the ropes on the computer, and for suprising me with his quiet and dry sense 
of humor, JT Mohr, Kevin Allan, Chris Gilmore, and Pam Tadross were extremely 
helpful during my formative years in the Stoltz lab.  I always admired Allen Hong’s quiet 
perseverance, and was always a helpful, friendly person to be around.  Hosea Nelson has 
magic Chemistry hands that force the most gnarly molecules into submission.  Yakup 
Gunes, my dear Turkish friend, probably learned as much English during his short stay 
here as he did Chemistry.  I remember one day when I asked how his Chemistry was 
going, and he showed me a vial containing about five grams of a well-advanced synthetic 
intermediate as if it was no big deal at all.  His modesty and his work ethic are extremely 
admirable.  In my latter years of grad school, I’m glad to have been able to tap into the 
energy and enthusiasm of the younger students in the lab, particularly my baymates Doug 
Duquette, Chung Whan Lee, and Corey Reeves.  Doug is outstandingly rigourous and 
methodical in his science, and generally a fun person to be around in spite of his musical 
tastes (hah!).  Corey holds himself to a very high standard, and his leadership by example 
has a way of improving the quality of research in the lab overall.  And it’s always a 
pleasure to talk with Chung Whan about his Chemistry as well as the finer details of 
Korean liquor!  Thanks are also due to Jeff Holder, Max Loewinger, Yiyang Liu, 
Christopher Haley, Kelly Kim, Seojung Han, Katerina Korch, Beau Pritchett, and Kelvin 
Bates. 
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I’ve had the fortune of collaborating with several talented scientists in and outside our 
group.  Rob Craig and Nick O’Connor were excellent collaborators as part of 
CyclopropaNation—though they won’t know I called our team that until they read this.  
Their hard work, creativity, eye for detail, and technical expertise was critical for our 
project’s advancement.  I’m excited to see what they have in store for the heterocumulene 
project; in addition, I look forward to seeing Nick’s creativity in C–H vinylation bear 
fruit.  I also greatly enjoyed working with Judith Su, a graduate student in the bioimaging 
department, on the functionalization of microtoroid optical resonators.  Together, we 
solved an array of technical problems that I would not have otherwise been exposed to in 
synthetic organic chemistry.  I had the opportunity to mentor two excellent undergraduate 
researchers, Aaron Levine and Chris Tonge.  From Chris’s first Grignard reaction, it was 
clear that organic synthesis would be second nature for him.  He has done excellent work 
on our ortho-quinone methide project, and has a bright future ahead of him in the field of 
Chemistry! 
Many thanks go to those who took the time to proof-read my thesis, including Rob 
Craig, Nick O’Connor, Doug Duquette, Christopher Haley and Yiyang Liu, in addition to 
Brian and my committee members.  Their suggestions and edits have improved 
considerably the quality of this work.  
I have made a number of friends since arriving at Caltech within the Chemistry 
department and beyond.  Foremost, thanks go out to my roommates past and present, 
Ethan Van Arnam, Judy Lattimer, and James McKone.  Between Saturday brunches in 
our backyard, movie nights, and farmers market visits, they have made my life outside 
lab fantastic.  I also thank my friend Pedro Coelho, who is an incredible combination of 
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intelligence, kindness, and ambition; and I’ll predict he wins a Nobel prize of some 
sort—say, in 2030—you heard it here first.  Thanks to Ariel Furst, a stellar chemist in the 
lab and in the kitchen.  And cheers to my cohorts in the Reisman lab, Roger, John, Jay, 
Lindsay, and Raul. 
The technical and support staff in our department are unlike any other.  Dr. Scott 
Virgil has been a tremendous resource during my time here.  He has rarely hesitated to 
set aside hours of his time to discuss technical or strategic problems that I’ve faced 
throughout my graduate studies.  Dr. Dave Vander Velde runs a top-notch NMR facility 
and has helped me with difficult experiments on numerous occasions.  Rick Gerhart has 
fixed more than my fair share of glassware, and it is always incredible to watch him in 
action—it exemplifies the interface between artistry and science.  Joe Drew never fails to 
track down missing packages, and is always good for a high-five or a fist-pound, which is 
pretty much the epic combination necessary to improve my spirits.  Agnes Tong is the 
greatest Graduate Program Administrator that a stressed-out graduate student could ask 
for—she can always be counted on for words of encouragement, or candy, whichever the 
medicine happens to be that day.  Lynne Martinez does an incredible job of keeping the 
house in order, has just about all the answers to everything, and is a great person to talk 
about vacation plans with.  Also, candy.  And Allen Hong and Nick O’Connor for candy 
too, and sometimes Jonny.  Candy is great. 
Beyond Caltech, several friends in Los Angeles deserve acknowledgement.  Robin 
and Andy Mandell have been wonderful LA parents to me, inviting me into their home 
whenever I needed an escape from Pasadena, and checking in once in a while to make 
sure I’m alive and well!  Also, a shout-out to my fellow CBC Radio 3 listeners in LA—
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Tim Aarons, Christine Hitchman, Seth Dallob, Kennedy Davey—all of the Canadian 
musicians who have passed through the city, and Grant Lawrence and the CBC hosts who 
have provided me with a healthy dose of culture, and who all served as my primary link 
to home.  And Michael van Vliet/Tall Michael/Motorcycle Michael, who served as a 
constant reminder that normal people, with normal people problems and normal people 
occupations do exist outside the confines of academia! 
I’d also like to thank the multitude of chemists with whom I have regularly interacted 
via social media, in no particular order, including Paul Bracher (good luck with your 
academic appointment!), Carmen Drahl, Matt Hartings, Stu Cantrill, Vy Tran, Freda 
Chio, Matt Katcher, anonymous bloggers “Organometallica”, “Chemjobber”, “BRSM”, 
“SeeArrOh”, and “Chemist Hulk”, of course (I hope to meet you all some day, if I 
haven’t already!  Except for Chemist Hulk). 
I’m glad to have kept in touch with so many of my friends from Toronto and at 
Queen’s, who have been so supportive of my work, and so understanding of the sacrifices 
I’ve had to make to progress through graduate school.  These are people with whom it 
has been so easy to pick up where I’ve left off when I’ve seen them back in Canada, or 
when they have visited me in LA.  Huge thanks go out to Alexandra Der, Erin Weinberg, 
Noah Bonder, Michelle Edwards, Leah Dacks, Daniel Stober, Andrew Leung, Caroline 
Cormier, Jordi Friese, Jon Goldberg, Robbie Agar, Mike Katz, Jeff Weiskopf, Joel 
Arshoff, Joanna Giddens.   
I’ve saved this last paragraph to thank the most important people in my life.  First of 
all, my family: Mom, Dad, Jessie, who don’t always understand why I work the hours 
that I do, but understand the ultimate goal of higher education.  For as long as I can 
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remember, my parents have nurtured my love of learning, and my sister has been my 
most important role model throughout my schooling. My parents have invested 
tremendously in my education, and have been so supportive of me every step of the way, 
providing me with every opportunity they could.  I look forward to spending the next two 
years with my sister and my new brother-in-law Aviv in Israel, as well as my extended 
family there. To my grandparents, my aunts, my uncles and my many cousins, I thank 
you all as well for your love and support.  I fondly remember sitting down with Nonnie in 
Detroit to study for Chemistry exams and competitions.  I have also been greatly inspired 
by the other PhDs and MDs in my family, including my grandfather, Dr. Ben Goldberg, 
my aunt Dr. Adele Goldberg and my uncle Dr. Joel Goldberg, my cousins Dr. Lynne 
Davis, Dr. David Weiner, and Dr. Shira Taylor and my cousin Yoni Weiner who is 
completing a Chemistry PhD at Imperial College.  Finally I thank Alyson who has, for 
the last year and a half, made my life wonderful by sharing in the joys and rigors of grad 
school, laughing at my horrible jokes, and talking through science challenges with me.  
Every day with her has been a new adventure, and she has been the most amazing person 
to share in every experience.  As a scientist, her creativity, intellect, and breadth of 
technical skill continues to be a tremendous source of inspiration for me. 
Thanks to all who have been a part of my life, taught and sustained me, and brought 







Donor–acceptor cyclopropanes are a versatile class of synthetic intermediates, 
compatible in a broad range of ring-opening reactions and formal cycloadditions, and 
employed in numerous natural product syntheses.  We have developed new Lewis acid 
mediated cycloadditions for the synthesis of five-membered heterocycles, and applied 
existing a transition metal catalyzed cyclopropane cycloaddition method toward the 
synthesis of complex alkaloids. 
First, described is the development of a Lewis acid mediated (3 + 2) cycloaddition of 
donor–acceptor cyclopropanes with isocyanates, isothiocyanates and carbodiimides.  This 
reaction was found in certain cases to proceed with excellent stereochemical fidelity, 
providing access to an array of enantioenriched thioimidates and amidines. 
Second, we targeted the Melodinus alkaloids for total synthesis due to their unique 
structural features.  Synthetic efforts toward scandine, the parent of the natural product 
family, are detailed herein.  Our approach features a palladium catalyzed formal (3 + 2) 
cycloaddition of a vinyl cyclopropane and a β-nitrostyrene to rapidly assemble the central 
cyclopentane core of the natural product.  Initial efforts focused on the synthesis and 
application of a 1,1-divinylcyclopropane to the formal (3 + 2) cycloaddition reaction, 
whereas later work entailed the use of a mono-vinylcyclopropane with the goal of 
installing the second requisite vinyl group at a later stage using modern C–H 
functionalization technologies. 
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°C  degrees Celsius 
ca. about (Latin circa) 
calc’d  calculated 
xxxi 
CAN ceric ammonium nitrate 
cat catalytic 
Cbz carbobenzyloxy 
CCDC  Cambridge Crystallographic Data Centre 
CDI  1,1'-carbonyldiimidazole  
cf. compare (Latin confer) 
CI  chemical ionization 
CID collision-induced dissociation 
cm–1 wavenumber(s) 
comp complex 
Cy  cyclohexyl 
d  doublet 
D deuterium 
dba  dibenzylideneacetone 
DBU  1,8-diazabicyclo[5.4.0]undec-7-ene 
DCE dichloroethane 
dec decomposition 
DIAD diisopropyl azodicarboxylate 
DMA N,N-dimethylacetamide 
DMAP  4-dimethylaminopyridine 
dmdba bis(3,5-dimethoxybenzylidene)acetone 
DMF  N,N-dimethylformamide 
DMSO  dimethyl sulfoxide 
DNA (deoxy)ribonucleic acid 
dppb  1,4-bis(diphenylphosphino)butane 
dppf 1,1'-bis(diphenylphosphino)ferrocene 
dr diastereomeric ratio 
xxxii 
EA activation energy 
EC50  median effective concentration (50%) 
EDC N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide 
ee  enantiomeric excess 
EI electron impact 
e.g. for example (Latin exempli gratia) 
equiv  equivalent 
ESI  electrospray ionization 
Et  ethyl 
FAB  fast atom bombardment 
FID flame ionization detector 
g  gram(s) 
GC gas chromatography 
gCOSY  gradient-selected correlation spectroscopy 
GlyPHOX 2-(2-(diphenylphosphino)phenyl)oxazoline 
h  hour(s) 




HPLC  high-performance liquid chromatography 
HRMS high-resolution mass spectroscopy 
HSV  herpes simplex virus 
hν light 
Hz  hertz 
IC50  median inhibition concentration (50%) 
i.e. that is (Latin id est) 
xxxiii 
IR  infrared (spectroscopy) 
J  coupling constant 
kcal kilocalorie 
KDA potassium diisopropylamide 
KHMDS potassium hexamethyldisilazide 
λ  wavelength 
L  liter 
LDA lithium diisopropylamide 
lit. literature value 
LTQ linear trap quadrupole 
m  multiplet; milli 
m  meta 
m/z  mass to charge ratio 
M metal; molar; molecular ion 
Me  methyl 
MHz  megahertz 
µ micro 
µwaves microwave irradiation 
min  minute(s) 
MM mixed method 
mol  mole(s) 
MOM methoxymethyl 
mp  melting point 
Ms  methanesulfonyl (mesyl) 




nbd  norbornadiene 
NBS  N-bromosuccinimide 
NIST National Institute of Standards and Technology 
NMO  N-methylmorpholine N-oxide 
NMR  nuclear magnetic resonance 
NOE  nuclear Overhauser effect 
NOESY  nuclear Overhauser enhancement spectroscopy 
Nu nucleophile 
[O]  oxidation 
o  ortho 
p  para 
PA proton affinity 
PCC pyridinium chlorochromate 
PDC  pyridinium dichromate 
Ph  phenyl 
pH  hydrogen ion concentration in aqueous solution 




pKa pK for association of an acid 
PMB p-methoxybenzyl 
pmdba bis(4-methoxybenzylidene)acetone 
ppm  parts per million 
PPTS pyridinium p-toluenesulfonate 
Pr  propyl 
i-Pr isopropyl 
xxxv 
Py  pyridine 
q  quartet 
ref reference 
R generic for any atom or functional group 
Rf  retention factor 
rt  room temperature 
s  singlet or strong or selectivity factor 
sat. saturated 
SET single electron transfer 
SN2 second-order nucleophilic substitution 
sp. species 
t  triplet 
TBAF  tetrabutylammonium fluoride 
TBHP tert-butyl hydroperoxide 
TBS  tert-butyldimethylsilyl 
TCDI 1,1’-thiocarbonyldiimidazole 
TCNE tetracyanoethylene 
Tf  trifluoromethanesulfonyl (trifyl) 
TFA  trifluoroacetic acid 
TFE 2,2,2-trifluoroethanol 
THF  tetrahydrofuran 
TIPS  triisopropylsilyl 
TLC  thin-layer chromatography 
TMEDA N,N,N’,N’-tetramethylethylenediamine 




TON turnover number 
tR retention time 
Ts  p-toluenesulfonyl (tosyl) 
UV  ultraviolet 
v/v volume to volume 
w  weak 
w/v weight to volume 
X anionic ligand or halide 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
